Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

NCT01293669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: TC-6987
DRUG: Placebo

Sponsor

Targacept Inc.